Vectura Group PLC (VEC) Insider Buys £148.52 in Stock

Vectura Group PLC (LON:VEC) insider Andrew Derodra acquired 158 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The shares were purchased at an average price of GBX 94 ($1.21) per share, with a total value of £148.52 ($191.81).

Andrew Derodra also recently made the following trade(s):

  • On Thursday, September 7th, Andrew Derodra acquired 82,000 shares of Vectura Group PLC stock. The shares were purchased at an average price of GBX 90 ($1.16) per share, with a total value of £73,800 ($95,311.89).
  • On Friday, August 4th, Andrew Derodra acquired 135 shares of Vectura Group PLC stock. The shares were purchased at an average price of GBX 111 ($1.43) per share, with a total value of £149.85 ($193.53).

Vectura Group PLC (LON:VEC) opened at 103.50 on Friday. The stock has a 50 day moving average of GBX 108.65 and a 200 day moving average of GBX 126.28. Vectura Group PLC has a 12-month low of GBX 88.90 and a 12-month high of GBX 166.97. The firm’s market cap is GBX 702.25 million.

COPYRIGHT VIOLATION WARNING: This article was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.chaffeybreeze.com/2017/09/15/vectura-group-plc-vec-insider-buys-148-52-in-stock.html.

VEC has been the subject of a number of analyst reports. Numis Securities Ltd restated a “buy” rating on shares of Vectura Group PLC in a report on Monday, May 22nd. Panmure Gordon reiterated a “buy” rating on shares of Vectura Group PLC in a report on Wednesday, August 30th. Shore Capital reiterated a “buy” rating on shares of Vectura Group PLC in a report on Wednesday, August 16th. Peel Hunt reiterated a “hold” rating and issued a GBX 160 ($2.07) price target on shares of Vectura Group PLC in a report on Wednesday, September 6th. Finally, N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a report on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of GBX 209 ($2.70).

About Vectura Group PLC

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.

Insider Buying and Selling by Quarter for Vectura Group PLC (LON:VEC)

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply